'Over 72pc of dialysis patients don't undergo prescribed

Image
Press Trust of India New Delhi
Last Updated : Jun 17 2015 | 4:13 PM IST
More than 72 per cent of the dialysis patients do not undergo the prescribed treatment, according to a study on patients' behaviour.
"While 3 sessions per week is the globally accepted minimum treatment modality for kidney failure, around 72 per cent patients in India opt for lesser frequency which adversely affecting their longevity and quality of life," the study by NephroPlus, a dialysis provider network, stated.
As per the findings, patient behaviour to "under-treat" themselves is an outcome of their lack of affordability and also understanding of the implications which puts them at risk of cardiac arrest.
The study involved over 1,300 patients across 10 states Andhra Pradesh, Karnataka, Maharashtra, Kerala, Tamil Nadu, Delhi, Telangana, Jharkhand, Uttarakhand and Uttar Pradesh and was done between January 2013 and July 2014.
"With more than 2 lakh people developing kidney failure every year, it is one of the most chronic epidemics to affect the country, but it is widely neglected.
"While there has been some improvement with some state governments' subsidising the dialysis treatment, the situation calls for greater participation from state and central governments," said Kamal Shah, cofounder and director of Patient Services, NephroPlus, who himself has been on dialysis for more than 18 years.
"Adoption of innovative models such as public private partnership can definitely make dialysis accessible and affordable," said Dr Umesh Khanna, Chairman of Mumbai Kidney Foundation.
The experts also called for strict implementation of infection-prevention protocols combined with clinical audits to contain the spread of cross infections.
As per the report, around 16 per cent of the dialysis patients across the country were affected by Hepatitis C which called for better quality treatment facilities across the country. Hepatitis C is one of the most dangerous cross infections that dialysis patients get infected.
Majority of people with Hepatitis C will proceed to liver cirrhosis necessitating a liver transplant further deteriorating the health and causing early mortality among dialysis patients.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 17 2015 | 4:13 PM IST

Next Story